Virus‐Induced, Tumour‐Associated Antigens

[1]  G. Klein,et al.  The Analysis of Malignancy by Cell Fusion: III. Hybrids Between Diploid Fibroblasts and Other Tumour Cells , 1971 .

[2]  G. Klein,et al.  Two-colour immunofluorescence studies on EBV-determined antigens. , 1971, Clinical and experimental immunology.

[3]  I. Ernberg,et al.  The action of dna antagonists on epstein‐barr virus (EBV)‐associated early antigen (EA) in burkitt lymphoma lines , 1971, International journal of cancer.

[4]  G. Klein,et al.  Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: Antibodies to EBV associated Membrane and Viral Capsid Antigens in Burkitt Lymphoma Patients , 1970, Nature.

[5]  G. Klein,et al.  Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx , 1970, Nature.

[6]  N. Wedderburn.  Effect of concurrent malarial infection on development of virus-induced lymphoma in Balb-c mice. , 1970, Lancet.

[7]  G. Klein,et al.  Epstein‐Barr virus (EBV)‐associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease , 1970, International journal of cancer.

[8]  T. Benjamin,et al.  Absence of a cell membrane alteration function in non-transforming mutants of polyoma virus. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Hirshaut,et al.  Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection. , 1970, The New England journal of medicine.

[10]  F. Rapp,et al.  Reaction of serum from pregnant hamsters with surface of cells transformed by SV40. , 1970, Journal of immunology.

[11]  W. Henle,et al.  Differential Reactivity of Human Serums with Early Antigens Induced by Epstein-Barr Virus , 1970, Science.

[12]  G. Klein,et al.  Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established burkitt lymphoma cell lines , 1970, International journal of cancer.

[13]  V. Defendi,et al.  Surface antigen(s) of SV40-transformed tumor cells. , 1970, Virology.

[14]  R. Witter,et al.  Studies on the epidemiology of Marek's disease herpesvirus in broiler flocks. , 1970, Avian diseases.

[15]  G. Klein,et al.  Comparison of the anti‐ebv titer and the ebv‐associated membrane reactive and precipitating antibody levels in the sera of burkitt lymphoma and nasopharyngeal carcinoma patients and controls , 1970, International journal of cancer.

[16]  G. Klein,et al.  The presence of Moloney virus induced antigen on antibody-producing cells. , 1970, Clinical and Experimental Immunology.

[17]  G. Klein,et al.  Clonal origin for individual Burkitt tumours. , 1970, Lancet.

[18]  L. Subrahmanyan,et al.  Prevalence, incidence and persistence of EB virus antibody in young adults. , 1970, The New England journal of medicine.

[19]  L. Sachs,et al.  The formation of variants with a reversion of properties of transformed cells. IV. Loss of detectable polyoma transplantation antigen. , 1970, Virology.

[20]  P. Burtin,et al.  Mise en évidence de l'antiéne carcinoembryonnaire spécifique des cancers digestifs dans des tumeurs humaines entretenues en culture organotypique , 1970 .

[21]  G. Klein,et al.  Malignancy of Somatic Cell Hybrids (reply) , 1969, Nature.

[22]  G. Klein,et al.  Some factors affecting membrane immunofluorescence reactivity of burkitt lymphoma tissue culture cell lines , 1969, International journal of cancer.

[23]  G. Klein,et al.  Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. , 1969, Clinical and experimental immunology.

[24]  A. Herbet,et al.  Antigènes nouveaux dans les cellules transformées par le SV40. I. Mise en évidence de trois nouveaux constituants antigéniques dans plusieurs lignées cellulaires d'origines différentes transformées par le SV40 , 1969 .

[25]  L. Sachs,et al.  Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Klein,et al.  Suppression of Malignancy by Cell Fusion , 1969, Nature.

[27]  G. Klein,et al.  EBV‐Associated serological patterns in a burkitt lymphoma patient during regression and recurrence , 1969, International journal of cancer.

[28]  G. Klein,et al.  RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE IN BURKITT TUMOR CELLS , 1969, The Journal of experimental medicine.

[29]  G. Klein,et al.  RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE IN BURKITT TUMOR CELLS , 1969, The Journal of experimental medicine.

[30]  M. Burger.  A difference in the architecture of the surface membrane of normal and virally transformed cells. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Klein,et al.  RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE OF BURKITT TUMOR CELLS , 1968, The Journal of experimental medicine.

[32]  L. Old,et al.  Serologic approaches to the study of cancer in animals and in man. , 1968, Cancer research.

[33]  M. Glick,et al.  Membranes of animal cells. II. The metabolism and turnover of the surface membrane. , 1968 .

[34]  H. Green,et al.  Growth control in cultured cells: selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing ability. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Dulbecco,et al.  Viral DNA in polyoma- and SV40-transformed cell lines. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[36]  F. Rapp,et al.  Development of S and T antigens and oncogenicity in hamster embryonic cell lines exposed to SV40. , 1968, Virology.

[37]  W. Joklik,et al.  Studies on the structural proteins of vaccinia virus. II. Kinetics of the synthesis of individual groups of structural proteins. , 1967, Virology.

[38]  P. Biggs,et al.  Agent of Marek's Disease in Tissue Culture , 1967, Nature.

[39]  P Clifford,et al.  Further studies on the membrane immunofluorescence reaction of Burkitt lymphoma cells , 1967, International journal of cancer.

[40]  P. Clifford.  Further studies on the treatment of Burkitt's lymphoma. , 1966, East African medical journal.

[41]  G. Klein,et al.  Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[42]  W. Henle,et al.  Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.

[43]  P. Gold,et al.  SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.

[44]  A. Girardi.  Prevention of SV40 virus oncogenesis in hamsters. I. Tumor resistance induced by human cells transformed by SV40. , 1965, Proceedings of the National Academy of Sciences of the United States of America.

[45]  H. Rubin.  GENETIC CONTROL OF CELLULAR SUSCEPTIBILITY TO PSEUDOTYPES OF ROUS SARCOMA VIRUS. , 1965, Virology.

[46]  H. O. Sjögren,et al.  Transplantation methods as a tool for detection of tumor-specific antigens. , 1965, Progress in experimental tumor research.

[47]  Ngu Va.  THE AFRICAN LYMPHOMA (BURKITT TUMOUR): SURVIVALS EXCEEDING TWO YEARS. , 1965 .

[48]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[49]  R. Huebner.  TUMOR VIRUS STUDY SYSTEMS , 1963, Annals of the New York Academy of Sciences.

[50]  S. Luria.  Bacteriophage Genes and Bacterial Functions , 1962, Science.

[51]  I. Macpherson.  The characteristics of animal cells transformed in vitro. , 1970, Advances in cancer research.

[52]  V. Diehl,et al.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Wildy,et al.  Serological relationships among viruses of the herpes group. , 1967, The Journal of general virology.